Adeel Arsalan, Zufi Shad, Arif Sabah, Farrukh Rafiq Ahmed, Aysha Malik, Osama Shakeel
Chronic obstructive pulmonary disease (COPD) has been one of the main causes of mortality world widely. The impact of COPD has been increased socio-economically with span of time. COPD has become fire alarming condition for health associated professionals due to the severity of prevalence and its expensive treatment. Due to COPD, patients’ not only suffers illness but also bears financial impacts. The main aim of present study was to determine the prevalence and the medication of COPD. Several propositions have been suggested regarding the pathophysiology of COPD. The medical records of patients suffering from COPD were collected from different tertiary care hospitals in Karachi from June 2011 to May 2012. The study has been comprised of middle adulthood stage to in mature age. In medical wards of different tertiary care hospitals in Karachi, Out of 1260 patients 174 (13.80%) were suffered from COPD. It has been noted nearly all the patients of COPD were associated with co-morbidity like diabetes mellitus, hypertension, urinary tract infections, renal failure, pneumonia, cardiovascular diseases, and other diseases. Anti-allergy, oxygen supply, intravenous and oral montilukast, atrovent and other nebulizers, cough syrups, inhalers, antibiotics, and other treatment were used for the treatment of COPD as directed by the world renowned guidelines for COPD. Major guidelines have been provided by various societies like British Thoracic Society, The Americans Thoracic Society, and European Respiratory Society to treat COPD. Spirometry, either in conjunction with a clinical examination or used alone, to reach a prevalence estimate.
